Shanghai Xuerong Biotechnology Co Ltd
SZSE:300511
Shanghai Xuerong Biotechnology Co Ltd
Cost of Revenue
Shanghai Xuerong Biotechnology Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shanghai Xuerong Biotechnology Co Ltd
SZSE:300511
|
Cost of Revenue
-¥2.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
Tongwei Co Ltd
SSE:600438
|
Cost of Revenue
-¥101.8B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-22%
|
|
H
|
Heilongjiang Agriculture Co Ltd
SSE:600598
|
Cost of Revenue
-¥3.3B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
7%
|
B
|
Beijing Dabeinong Technology Group Co Ltd
SZSE:002385
|
Cost of Revenue
-¥30.5B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-10%
|
New Hope Liuhe Co Ltd
SZSE:000876
|
Cost of Revenue
-¥129.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-7%
|
|
Jiangxi Zhengbang Technology Co Ltd
SZSE:002157
|
Cost of Revenue
-¥6.4B
|
CAGR 3-Years
47%
|
CAGR 5-Years
21%
|
CAGR 10-Years
8%
|
See Also
What is Shanghai Xuerong Biotechnology Co Ltd's Cost of Revenue?
Cost of Revenue
-2.3B
CNY
Based on the financial report for Sep 30, 2023, Shanghai Xuerong Biotechnology Co Ltd's Cost of Revenue amounts to -2.3B CNY.
What is Shanghai Xuerong Biotechnology Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-8%
Over the last year, the Cost of Revenue growth was -14%. The average annual Cost of Revenue growth rates for Shanghai Xuerong Biotechnology Co Ltd have been -12% over the past three years , -8% over the past five years .